More Publishers Now Offering Audience Extension to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
More Publishers Now Offering Audience Extension to Advertisers, Says Rocket Fuel Audience Accelerator and Digiday Survey

REDWOOD CITY, CA--(Marketwired - Sep 18, 2014) - With the growth of programmatic solutions that enable publishers to use their valuable first party data to monetize their audiences beyond their owned and operated sites, publishers are expanding their ad offering with audience extension. According to survey results released today by media company Digiday and Audience Accelerator, a business unit within Rocket Fuel , ( NASDAQ : FUEL ), a leading provider of artificial intelligence (AI) advertising solutions for digital marketers, 77% of publishers now say they are "very familiar" with audience extension, underlining a significant shift from a year ago overall (+23% increase in familiarity). Audience Accelerator and Digiday published a similar state of the industry survey in October of 2013.

Audience Accelerator and Digiday's "The Value of Digital Publisher's Audiences" survey questioned 226 senior level publishers and agency and brand professionals. The insights in the study highlight shifts on both the publisher and buyer sides over the past year and anticipated future shifts. Key findings from the study include:

Publishers are looking to audience extension solutions to increase their revenue through greater reach:

  • More than half of publishers (52%) are offering audience extension to their advertising partners, an increase from last year's results.
  • Publishers offering audience extension are leveraging it more often, with one third (33%) of publishers saying that they offer audience extension solutions on either "most" or "all" of their campaign proposals to advertisers, a 31% increase from 2013.
  • Most (73%) publishers offering audience extension say they include extension on a proposal when they need additional reach to deliver on advertiser goals, an increase of more than 55% from the 2013 survey.
  • Publishers are seeing more benefits overall, primarily when it comes to meeting goals for clients -- two thirds of publishers (67%) say that audience extension has allowed them to meet client goals that would have otherwise not been met, nearly double the number one year ago.
  • Audience extension is generating up to 10% of practicing publishers' revenue. 36% of publishers report that they plan for it to account for between 11% and 20% of advertising revenue over the next 12 months.

Publishers are more sophisticated than they were a year ago, with a greater understanding of the benefits of extension:

  • Publishers are 23% more likely to say that they are "very familiar" with audience extension than they were a year ago, with more than 3 out of 4 (77%) claiming this level of familiarity.

Publishers looking to the future want better reporting tools and more transparency from audience extension platforms:

  • A direct consequence of greater levels of familiarity and sophistication is a greater understanding of the benefits a publisher can receive from audience extension. 
  • Publishers state Transparency (14%) and Easier Access to the Platform (14%) as the top two items they would prefer to see in the future development of audience extension.

"At Digiday we know just how fast digital publishing is changing, not just because we write about it, but because we're a part of it," said Nick Friese, Digiday CEO. "Publishers are under pressure to deliver large, quality audiences and this Industry Leader's study explores just how they're expanding those audiences to meet demand. We'll be listening to the findings and insights revealed by this study just as eagerly as anyone in the DPS audience this month."

"Audience Accelerator is deeply vested in helping the market make informed decisions regarding audience extension," said Paul Wenz, Audience Accelerator General Manager. "By partnering with Digiday, we are able to keep our fingers on the pulse of the market, retrieving unbiased responses for how publishers, buyers and brands value publishers' first party data and in particular the practice of audience extension."

For more information and to review the full report, please visit http://rocketfuel.com/audiencevalue .

Methodology A sample of 226 publishers, and agency and brand professionals -- at the director level or higher -- responded to this survey as part of the Digiday Executive Forum. The survey was fielded between August 13th and September 5th. Publishers involved in the Executive Forum range in audience size from less than 250,000 uniques per month to more than 50 million uniques per month.

About Audience Accelerator Rocket Fuel's Audience Accelerator business unit provides an unparalleled full-service audience extension platform, exclusively servicing sites, networks and data companies. We help our partners leverage their data to effortlessly scale their audiences with outstanding results. Powered by our proven artificial intelligence technology, we enable our partners to model their unique audiences and extend reach to up to 99% of the online universe in the United States. Audience Accelerator's full-service team handles set up, training, and execution. We provide access to industry experts; RFP responses; and detailed, actionable campaign analysis -- saving technology, staff, and infrastructure investment.

About Rocket Fuel Rocket Fuel delivers a leading programmatic media-buying platform at Big Data scale that harnesses the power of artificial intelligence (AI) to improve marketing ROI in digital media across web, mobile, video, and social channels. Rocket Fuel powers digital advertising and marketing programs globally for customers in North America, Europe, and APAC. Customers trust Rocket Fuel's Advertising That Learns® platform to achieve brand and direct-response objectives in diverse industries from luxury cars to financial services to retail. Rocket Fuel currently operates in more than 20 offices worldwide and trades on the NASDAQ Global Select Market under the ticker symbol "FUEL." For more information, please visit http://www.rocketfuel.com or call 1-888-717-8873.

Media Contact: Kenya Hayes khayes@rocketfuel.com 650-481-6178

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 31

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Bank of Canada Considers Interest Rate Cuts Amid Growth Concerns

Updated Category News Views 91

Bank of Canada Considers Possible Rate Cuts Recent discussions reported by the Financial Times reveal that Governor Tiff Macklem of the Bank of Canada has started exploring the possibility of increasing the pace at which interest rates could be cut. This potential shift highlights the Bank's response to growing concerns about the Canadian economy's current dynamics....

Continue Reading
Photonics Market Poised for Massive Growth by 2030

Updated Category News Views 151

Understanding the Photonics Market Growth The photonics industry is on an impressive trajectory, with projections indicating it will grow significantly over the coming years. Experts foresee the market expanding from approximately USD 1,093.96 billion to an astounding USD 1,481.80 billion by 2030, reflecting a compound annual growth rate (CAGR) of around 6.3%. This rapid...

Continue Reading
Brookfield Infrastructure Plans Redemption of Preferred Units

Updated Category News Views 154

Brookfield Infrastructure Announces Series 3 Redemption Plan BROOKFIELD, News - Brookfield Infrastructure Partners L.P. (TSX: BIP.UN; NYSE: BIP) has announced its intention to redeem all outstanding Cumulative Class A Preferred Limited Partnership Units, Series 3 (the “Series 3 Preferred Units”). This strategic decision aims to enhance their portfolio's financial...

Continue Reading
How a $1000 Investment in Enphase Energy Grew to $3200

Updated Category News Views 147

Transforming $1000 into $3200 with Enphase Energy Investing can be a journey filled with uncertainties, but the story of Enphase Energy (NASDAQ: ENPH) reveals a powerful lesson in the potential of financial growth. Over the past five years, Enphase Energy has impressively outperformed many market benchmarks, achieving a remarkable annualized return of 26.49%. At present,...

Continue Reading
Investors Should Pay Attention: Rocket Pharmaceuticals Lawsuit Update

Updated Category News Views 191

The Class Action Lawsuit Against Rocket Pharmaceuticals Recently, investors of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) have been advised to participate in a class action lawsuit for potential securities fraud. This lawsuit arises from significant concerns over the company's disclosure practices and the impact of leadership decisions on stock performance. If you are an...

Continue Reading